The frequencies of overall and individual AEs were not markedly different between the normal- and low-eGFR groups in the present study, although AEs associated with SGLT2 inhibitor use are generally more frequently observed in subjects with renal dysfunction than in those without it [11,23–25,47]. The gene discussed is SLC5A2; the disease is Abnormal renal physiology.